Choose the healthy way! Physical activity as a tool to improve mental health in young cancer survivors
Acta Oncol. 2023 Oct 14:1-3. doi: 10.1080/0284186X.2023.2270154. Online ahead of print.NO ABSTRACTPMID:37837211 | DOI:10.1080/0284186X.2023.2270154 (Source: Acta Oncologica)
Source: Acta Oncologica - October 14, 2023 Category: Cancer & Oncology Authors: Ambra Gentile Salvatore Ficarra Sonia Ortega-G ómez David Jim énez-Pavón Zoi Asimakopoulou Apostolos Vantarakis Paula Tavares Vasco Vaz Joshua Thaller Sofia Papakonstantinou Musa Kirkar Francesca Glorioso Marina Galioto Mario Lo Mauro Antonino Bianco Source Type: research

Parameters for proton minibeam radiotherapy using a clinical scanning beam system
Acta Oncol. 2023 Oct 14:1-5. doi: 10.1080/0284186X.2023.2266125. Online ahead of print.NO ABSTRACTPMID:37837215 | DOI:10.1080/0284186X.2023.2266125 (Source: Acta Oncologica)
Source: Acta Oncologica - October 14, 2023 Category: Cancer & Oncology Authors: Fardous Reaz Mateusz Krzysztof Sitarz Erik Traneus Niels Bassler Source Type: research

Pregnancy outcomes in female survivors of neuroblastoma: a short report from the Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study
Acta Oncol. 2023 Oct 14:1-7. doi: 10.1080/0284186X.2023.2266567. Online ahead of print.NO ABSTRACTPMID:37837234 | DOI:10.1080/0284186X.2023.2266567 (Source: Acta Oncologica)
Source: Acta Oncologica - October 14, 2023 Category: Cancer & Oncology Authors: Arezo Azizi Filippa N Norsker Marietta Kokla Thomas T Nielsen Anna S Holmqvist Ingrid Øra Kim Vettenranta Hilde Øfstaas Henrik Hasle Catherine Rechnitzer Jeanette F Winther Line Kenborg Source Type: research

HPV testing versus p16 immunohistochemistry in oropharyngeal squamous cell carcinoma: results from the DAHANCA 19 study
CONCLUSION: In the present study, HPV DNA testing or typing in a Danish OPSCC cohort did not add additional information to p16 IHC, the most widely used and accepted prognostic indicator.PMID:37837201 | DOI:10.1080/0284186X.2023.2266127 (Source: Acta Oncologica)
Source: Acta Oncologica - October 14, 2023 Category: Cancer & Oncology Authors: Jacob Kinggaard Lilja-Fischer Morten Horsholt Kristensen Pernille Lassen Torben Steiniche Trine Tramm Magnus Stougaard Christian Maare J ørgen Johansen Hanne Primdahl Claus Andrup Kristensen Maria Andersen Jesper Grau Eriksen Jens Overgaard Source Type: research

Choose the healthy way! Physical activity as a tool to improve mental health in young cancer survivors
Acta Oncol. 2023 Oct 14:1-3. doi: 10.1080/0284186X.2023.2270154. Online ahead of print.NO ABSTRACTPMID:37837211 | DOI:10.1080/0284186X.2023.2270154 (Source: Acta Oncologica)
Source: Acta Oncologica - October 14, 2023 Category: Cancer & Oncology Authors: Ambra Gentile Salvatore Ficarra Sonia Ortega-G ómez David Jim énez-Pavón Zoi Asimakopoulou Apostolos Vantarakis Paula Tavares Vasco Vaz Joshua Thaller Sofia Papakonstantinou Musa Kirkar Francesca Glorioso Marina Galioto Mario Lo Mauro Antonino Bianco Source Type: research

Parameters for proton minibeam radiotherapy using a clinical scanning beam system
Acta Oncol. 2023 Oct 14:1-5. doi: 10.1080/0284186X.2023.2266125. Online ahead of print.NO ABSTRACTPMID:37837215 | DOI:10.1080/0284186X.2023.2266125 (Source: Acta Oncologica)
Source: Acta Oncologica - October 14, 2023 Category: Cancer & Oncology Authors: Fardous Reaz Mateusz Krzysztof Sitarz Erik Traneus Niels Bassler Source Type: research

Pregnancy outcomes in female survivors of neuroblastoma: a short report from the Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study
Acta Oncol. 2023 Oct 14:1-7. doi: 10.1080/0284186X.2023.2266567. Online ahead of print.NO ABSTRACTPMID:37837234 | DOI:10.1080/0284186X.2023.2266567 (Source: Acta Oncologica)
Source: Acta Oncologica - October 14, 2023 Category: Cancer & Oncology Authors: Arezo Azizi Filippa N Norsker Marietta Kokla Thomas T Nielsen Anna S Holmqvist Ingrid Øra Kim Vettenranta Hilde Øfstaas Henrik Hasle Catherine Rechnitzer Jeanette F Winther Line Kenborg Source Type: research

Large scale experience of two ultrahypofractionated 5 fractions regimes after breast conserving surgery from a single centre
CONCLUSIONS: ultrahypofractionated radiotherapy was associated with an excellent tumor control rate in our 'real-life' cohort with low-risk breast cancer patients. However, delivery of a tumor bed boost and using weekly 5.7-Gy fractions were associated with an increased risk of acute and late cutaneous toxicities.PMID:37824092 | DOI:10.1080/0284186X.2023.2267170 (Source: Acta Oncologica)
Source: Acta Oncologica - October 12, 2023 Category: Cancer & Oncology Authors: Louis-Marie Sauvage Pierre Loap Jeremi Vu-Bezin Kim Cao Manon Kissel Sol ène Bringer Safia Maraadji Alain Fourquet Youlia Kirova Source Type: research

Large scale experience of two ultrahypofractionated 5 fractions regimes after breast conserving surgery from a single centre
CONCLUSIONS: ultrahypofractionated radiotherapy was associated with an excellent tumor control rate in our 'real-life' cohort with low-risk breast cancer patients. However, delivery of a tumor bed boost and using weekly 5.7-Gy fractions were associated with an increased risk of acute and late cutaneous toxicities.PMID:37824092 | DOI:10.1080/0284186X.2023.2267170 (Source: Acta Oncologica)
Source: Acta Oncologica - October 12, 2023 Category: Cancer & Oncology Authors: Louis-Marie Sauvage Pierre Loap Jeremi Vu-Bezin Kim Cao Manon Kissel Sol ène Bringer Safia Maraadji Alain Fourquet Youlia Kirova Source Type: research

Ulcerative lymphomatoid papulosis following immune checkpoint inhibition and autologous stem cell transplant in a patient with recurrent Hodgkin lymphoma: a case report
Acta Oncol. 2023 Oct 11:1-5. doi: 10.1080/0284186X.2023.2258448. Online ahead of print.NO ABSTRACTPMID:37819261 | DOI:10.1080/0284186X.2023.2258448 (Source: Acta Oncologica)
Source: Acta Oncologica - October 11, 2023 Category: Cancer & Oncology Authors: Lindsay M Pattison Mina Aziz Mendel Goldfinger Bijal Amin Beth N McLellan Source Type: research

Ulcerative lymphomatoid papulosis following immune checkpoint inhibition and autologous stem cell transplant in a patient with recurrent Hodgkin lymphoma: a case report
Acta Oncol. 2023 Oct 11:1-5. doi: 10.1080/0284186X.2023.2258448. Online ahead of print.NO ABSTRACTPMID:37819261 | DOI:10.1080/0284186X.2023.2258448 (Source: Acta Oncologica)
Source: Acta Oncologica - October 11, 2023 Category: Cancer & Oncology Authors: Lindsay M Pattison Mina Aziz Mendel Goldfinger Bijal Amin Beth N McLellan Source Type: research

Geometric distortions in clinical MRI sequences for radiotherapy: insights gained from a multicenter investigation
CONCLUSION: There is a large variation in the geometric distortion levels of clinical MRI sequences across Danish RT centers, and between anatomical sites. The large variation observed makes harmonization of MRI sequences across institutions and adoption of practices from well-performing anatomical sites, a relevant measure within RT.PMID:37815867 | DOI:10.1080/0284186X.2023.2266560 (Source: Acta Oncologica)
Source: Acta Oncologica - October 10, 2023 Category: Cancer & Oncology Authors: Signe Winther Hasler Jesper Folsted Kallehauge Rasmus Hvass Hansen Eva Sams øe Dennis Tideman Arp Henrik Dahl Nissen Jens M Edmund Uffe Bernchou Faisal Mahmood Source Type: research

Dose planning study of proton versus photon radiotherapy for head and neck squamous cell carcinoma of unknown primary in the primary and recurrent setting
CONCLUSION: Omitting contralateral nCTV irradiation and mCTV irradiation will significantly reduce toxicity. The accumulated high dose volumes can be minimised using protons for re-irradiation. However, the use of protons for primary treatment provides limited benefit in most patients.PMID:37815913 | DOI:10.1080/0284186X.2023.2263156 (Source: Acta Oncologica)
Source: Acta Oncologica - October 10, 2023 Category: Cancer & Oncology Authors: Anne Ivalu Sander Holm Ulrik Vindelev Elstr øm Signe Bergliot Nielsen Kenneth Jensen Source Type: research

Clinical outcomes of < em > ALK < /em > + non-small cell lung cancer in Denmark
CONCLUSION: This study gives insights into the treatment and outcome of ALK+ NSCLC patients in Denmark and provides a real-world confirmation of the superior disease control provided by 2nd generation ALK-TKIs as compared to the 1st generation ALK-TKI crizotinib.PMID:37815923 | DOI:10.1080/0284186X.2023.2263153 (Source: Acta Oncologica)
Source: Acta Oncologica - October 10, 2023 Category: Cancer & Oncology Authors: Karin Holmskov Hansen Jakob Sidenius Johansen Edyta Maria Urbanska Peter Meldgaard Peter Hjorth-Hansen Charlotte Kristiansen Miroslaw Stelmach Eric Santoni-Rugiu Maiken Parm Ulh øi Anders Bondo Dydensborg Christina D ünweber Jon Lykkegaard Andersen Source Type: research

Locoregional breast radiotherapy including IMN: optimizing the dose distribution using an automated non-coplanar VMAT-technique
CONCLUSION: ncVMAT reduced doses to the heart and ipsilateral lung as compared to both cVMAT and 3D-CRT. All contralateral dose metrics were reduced with the novel ncVMAT technique compared to cVMAT, and the mean contralateral breast doses were similar to 3D-CRT.PMID:37812070 | DOI:10.1080/0284186X.2023.2264488 (Source: Acta Oncologica)
Source: Acta Oncologica - October 9, 2023 Category: Cancer & Oncology Authors: Jomar Frengen Johan Vikstr öm Ingvil Mjaaland Marit Funderud Sigrun Saur Almberg Kjell Ivar Dybvik Mari Helene Blihovde Hjelstuen Source Type: research